| Xanthine scaffold: scope and potential in drug development N Singh, AK Shreshtha, MS Thakur, S Patra Heliyon 4 (10), 2018 | 109 | 2018 |
| Phosphodiesterase 9: insights from protein structure and role in therapeutics N Singh, S Patra Life sciences 106 (1-2), 1-11, 2014 | 29 | 2014 |
| Development of xanthine based inhibitors targeting phosphodiesterase 9A N Singh, P Saravanan, MS Thakur, S Patra Letters in Drug Design & Discovery 14 (10), 1122-1137, 2017 | 9 | 2017 |
| Identification of xanthine derivatives as inhibitors of phosphodiesterase 9A through in silico and biological Studies N Singh, S Patra, S Patra Combinatorial Chemistry & High Throughput Screening 21 (7), 476-486, 2018 | 5 | 2018 |
| A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST)- an important target for development of substrate reduction therapy against … N Singh, AK Singh International Journal of Biological Macromolecules, 2023 | 3 | 2023 |
| In Silico Structural modeling and binding site analysis of Cerebroside Sulfotransferase (CST)– a therapeutic target for developing substrate reduction therapy for Metachromatic … N Singh, AK Singh ACS Omega, 2024 | 1 | 2024 |
| Diversifying the xanthine scaffold for potential phosphodiesterase 9A inhibitors: synthesis and validation N Singh, AH Malik, PK Iyer, S Patra Medicinal Chemistry Research 30, 1199-1219, 2021 | 1 | 2021 |
| Screening of phytoconstituents from Bacopa monnieri (L.) Pennell and Mucuna pruriens (L.) DC. to identify potential inhibitors against Cerebroside Sulfotransferase. N Singh, AK Singh PLOS ONE (Accepted), 2024 | | 2024 |
| Algal phycobiliproteins Royal Society of Chemistry (RSC) (under review), 2024 | | 2024 |
| In silico modeling and binding site analysis of Cerebroside Sulfotransferase (CST) – an important therapeutic target for developing substrate reduction therapy of Metachromatic … N Singh, AK Singh 2nd Rare Genetic Diseases Research Summit (REDRESS – 2023), 2023 | | 2023 |
| Computational modeling and binding site analysis of Cerebroside Sulfotransferase (CST) – an important therapeutic target for developing substrate reduction therapy of … N Singh, AK Singh 4th World Congress on Drug Discovery and Development - 2023, 2023 | | 2023 |
| Proteomic profile of diabetic nephropathy and promoting renal progenitors in diabetic mice N Singh, A Kesharwani, RL Gajbhiyea, P Ramalingam, A Dande, P Nikhil, ... 14th Annual Meeting of the Proteomics Society and International Conference …, 2022 | | 2022 |
| Xanthine as a scaffold for synthesis of novel compounds. N Singh, AH Malik, PK Iyer, S Patra IN Patent, Intellectual Property India, 2021 | | 2021 |
| Xanthine based inhibitors for therapeutics targeting phosphodiesterase 9A N Singh IIT Guwahati, 2016 | | 2016 |
Sanjukta PatraIIT Guwahati在 iitg.ernet.in 的电子邮件经过验证
